Therapeutic effect of Lactobacillus acidophilus-SDC 2012, 2013 in patients with irritable bowel syndrome

Digestive Diseases and Sciences

Volumn 53, Issue 10, 2008, Pages 2714-2718

  Sinn, Dong Hyun ^a   Song, Ji Hyun ^b   Kim, Hoi Jin ^a   Lee, Jun Haeng ^a   Son, Hee Jung ^a   Chang, Dong Kyung ^a   Kim, Young Ho ^a   Kim, Jae J ^a   Rhee, Jong Chul ^a   Rhee, Poong Lyul ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Seoul National University Hospital Healthcare System Gangnam Center   (South Korea)

Author keywords

Irritable bowel syndrome; Lactobacillus acidophilus; Probiotics

Indexed keywords

PLACEBO; PROBIOTIC AGENT;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; FEMALE; HUMAN; IRRITABLE COLON; LACTOBACILLUS ACIDOPHILUS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; FEMALE; HUMANS; IRRITABLE BOWEL SYNDROME; KOREA; LACTOBACILLUS ACIDOPHILUS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PROBIOTICS; TREATMENT OUTCOME;

EID: 50949100435     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-007-0196-4     Document Type: Article

References (19)

1. J Schrezenmeir M de Vrese 2001 Probiotics, prebiotics, and synbiotics-approaching a definition Am J Clin Nutr 73 361S 364S
2. MH Floch KK Madsen DJ Jenkins S Guandalini JA Katz A Onderdonk WA Walker RN Fedorak M Camilleri 2006 Recommendations for probiotic use J Clin Gastroenterol 40 275 278
3. EM Quigley B Flourie 2007 Probiotics and irritable bowel syndrome: a rationale for their use and an assessment of the evidence to date Neurogastroenterol Motil 19 166 172
4. S Nobaek ML Johansson G Molin S Ahrne B Jeppsson 2000 Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome Am J Gastroenterol 95 1231 1238
5. K Niedzielin H Kordecki B Birkenfeld 2001 A controlled, double-blind, randomized study on the efficacy of Lactobacillus plantarum 299V in patients with irritable bowel syndrome Eur J Gastroenterol Hepatol 13 1143 1147
6. HJ Kim M Camilleri S McKinzie MB Lempke DD Burton GM Thomforde AR Zinsmeister 2003 A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome Aliment Pharmacol Ther 17 895 904
7. L O'Mahony J McCarthy P Kelly G Hurley F Luo K Chen GC O'Sullivan B Kiely JK Collins F Shanahan EM Quigley 2005 Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles Gastroenterology 128 541 551
8. PL Rhee 2006 Definition and epidemiology of irritable bowel syndrome Korean J Gastroenterol 47 94 100
9. GF Longstreth WG Thompson WD Chey LA Houghton F Mearin RC Spiller 2006 Functional bowel disorders Gastroenterology 130 1480 1491
10. KW Heaton J Radvan H Cripps RA Mountford FE Braddon AO Hughes 1992 Defecation frequency and timing, and stool form in the general population: a prospective study Gut 33 818 824
11. EJ Irvine WE Whitehead WD Chey K Matsueda M Shaw NJ Talley SJ van Veldhuyzen Zanten 2006 Design of treatment trials for functional gastrointestinal disorders Gastroenterology 130 1538 1551
12. Wilson A, Longstreth GF, Knight K, Wong J, Wade S, Chiou CF, Barghout V, Frech F, Ofman JJ (2004) Quality of life in managed care patients with irritable bowel syndrome. Manag Care Interface 17:24-28, 34
13. GF Longstreth A Wilson K Knight J Wong CF Chiou V Barghout F Frech JJ Ofman 2003 Irritable bowel syndrome, health care use, and costs: a U.S. managed care perspective Am J Gastroenterol 98 600 607
14. M Camilleri 2006 Probiotics and irritable bowel syndrome: rationale, putative mechanisms, and evidence of clinical efficacy J Clin Gastroenterol 40 264 269
15. T Ringel-Kulka Y Ringel 2007 Probiotics in irritable bowel syndrome: has the time arrived? Gastroenterology 132 813 816 discussion 816
16. SM Riordan R Kim 2006 Bacterial overgrowth as a cause of irritable bowel syndrome Curr Opin Gastroenterol 22 669 673
17. AI Sharara E Aoun H Abdul-Baki R Mounzer S Sidani I Elhajj 2006 A randomized double-blind placebo-controlled trial of rifaximin in patients with abdominal bloating and flatulence Am J Gastroenterol 101 326 333
18. K Kajander K Hatakka T Poussa M Farkkila R Korpela 2005 A probiotic mixture alleviates symptoms in irritable bowel syndrome patients: a controlled 6-month intervention Aliment Pharmacol Ther 22 387 394
19. M Camilleri 2006 Is there a role for probiotics in irritable bowel syndrome? Dig Liver Dis 38 Suppl 2 S266 S269